CLINICAL TRIALS PROFILE FOR DENAVIR
✉ Email this page to a colleague
All Clinical Trials for DENAVIR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03521479 ↗ | A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis | Terminated | Squarex, LLC | Phase 2 | 2018-03-12 | Primary Objective: To assess local and generalized adverse events with repeat topical application of 2% and 0.5% squaric acid dibutyl ester (SADBE) in subjects with frequent herpes labialis (4 or more episodes in the previous 12 months). Secondary Objective: To assess efficacy of repeat topical application of 2% and 0.5% SADBE in the prevention of herpes labialis episodes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DENAVIR
Condition Name
Clinical Trial Locations for DENAVIR
Trials by Country
Clinical Trial Progress for DENAVIR
Clinical Trial Phase
Clinical Trial Sponsors for DENAVIR
Sponsor Name